Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy
Clinical trial NCT07091370 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07091370
- Sponsor
- Juventas Cell Therapy Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-27
- Primary completion
- 2026-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.